Chairman and Founder The Repair Stem Cell Institute™ www.repairstemcells.org Email: don@repairstemcells.org
How does a guy from Philadelphia who spent nearly 40 years as an executive in the insurance business, and is a charter member of the American Academy of Actuaries, come to be known worldwide as “a visionary,” “a humanitarian,” and “a voice in the wilderness” in the world of medicine? Don Margolis, 75, is a graduate of Drexel Institute of Technology (now Drexel University). Since 2003, Don has been quietly earning the title of “The Voice of Stem Cell Science” for his tireless advocacy of the efficacy of Adult Stem Cells – more accurately named Repair Stem Cells (RSC) – to help patients recover from more than 130 different diseases and medical conditions including many types of cancers; Multiple Sclerosis; congestive heart failure, COPD; Parkinson’s and Cerebral Palsy, hyperplasia, diabetes; and especially spinal cord injuries and Don’s personal favorite, Autism! In a recent interview, Mr. Margolis said, “I am not a crusader. My only agenda is to help patients who are told by the worst medical system in the developed world that their medical conditions are untreatable when that’s simply not true.” (Mr. Margolis’s claim of the worst is supported by the prestigious Commonwealth Fund’s National Scorecard on U.S. Health System Performance, 2008.)
Margolis describes his personal mission in life as “to bring a major medical benefit to mankind.” Most people who have no medical or scientific training would sit around wondering how to do it. Not Don. In 2003, he founded the world’s very first stem cell treating company, TheraVitae (www.vescell.com) and since then, almost 400 heart patients, looking at three choices, found a fourth:
American boxing legend Muhammad Ali will undergo Repair Stem Cell treatment for Parkinson’s syndrome.
A history of the EMBRYONIC STEM CELL HOAX, with special attention paid to the role Geron played.
42-year-old HIV/Leukemia patient has no detectable HIV after a Repair Stem Cell transplant.
A news story out yesterday exemplifies the “successes” of embryonic stem cells.
A dilated cardiomyopathy patient's ejection fraction has gone up from 23% to 41% after 6 months following stem cell treatment...